Jordan O’Donoghue did an amazing job presenting his work on the STING pathway and its role in preventing chemoresistance in Osteosarcoma UCD SBBS Research Day #SBBSRD24 #ThiswillSTING #osteosarcoma

My best friend Ana Pau Orgambide and I had the opportunity to work with Dr. Leticia Rocha Zavaleta in the protocol “Reversion of chemoresistance in colorectal cancer with the use of nifuroxazide” and present it at FacultadCienciasdelaSaludUP.
We had the fortune to win the 2. Place in research.

Update on the new happenings in the #CarpenterLab on pancreatic cancer evolution, metastasis, and chemoresistance at the U-M Rogel Cancer Center Basic Science Retreat 💪🏼

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer dlvr.it/T6JrYH

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer
biorxiv.org/content/10.110…

Excited to share our meta-analysis of dMMR and MSI-H in UC! These occur more in UTUC than bladder cancer. And similar to rectal cancer, occur more in localized stage, and may predict ICB sensitivity and chemoresistance. bmjoncology.bmj.com/content/3/1/e0… Andrea Apolo, M.D. Giovanni Maria Iannantuono

Warburg effect can confer chemoresistance through enhancing HR and suggest a potential therapeutic strategy of targeting MRE11 lactylation to mitigate the effects.

cell.com/cell/abstract/…

Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem ... biorxiv.org/cgi/content/sh… #biorxiv_cancer

Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence dlvr.it/T6FV5y

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer dlvr.it/T65nWz

Exosome secretion related gene signature predicts chemoresistance in patients with colorectal cancer dlvr.it/T63J1P

📢Alerta de seminario del PROGRAMA DISCIPLINARIO DE INMUNOLOGÍA

'CISPLATIN CHEMORESISTANCE IN OVARIAN CANCER: IMBALANCE BETWEEN EXOSOME...' dictado por manuel varas Universidad San Sebastián

Viernes 26 de abril 2024 9.15h

Sala Alberto Donoso “A” 2do piso, Sector F Facultad de Medicina

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer biorxiv.org/cgi/content/sh… #bioRxiv

Platinum-induced upregulation of #ITGA6 promotes #chemoresistance and spreading in #OvarianCancer .

By A. Gambelli, A. Nespolo, M. Sonego, G. Baldassarre & colleagues Centro di Riferimento Oncologico

🗞️doi.org/10.1038/s44321…

Looking to do a #PhD ? Want to learn about osteosarcoma chemoresistance, transcriptomics and proteomics? Come join Maria Secrier and myself at @UCL!

Very grateful to @SarcomaUK for funding this position - exciting as my first studentship as a PI!

Apply by 15th May. Details:

onlinelibrary.wiley.com/doi/10.1002/ct…

Hot off the press! UTHSC Pathology Residency UTHSC Research CTM #PathTwitter

“WNT5B drives osteosarcoma stemness, chemoresistance and metastasis”

Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1

bioengineer.org/microbiota-ent…

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer dlvr.it/T65jx0

findaphd.com/phds/project/e…

Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence [NEW RESULTS] dlvr.it/T6FHcl